Page last updated: 2024-08-23

raloxifene hydrochloride and Esophageal Neoplasms

raloxifene hydrochloride has been researched along with Esophageal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brookhart, MA; Patrick, A; Solomon, DH1
Ansar, A; Hussey, DJ; Sukocheva, OA; Watson, DI; Wee, C1

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Esophageal Neoplasms

ArticleYear
More on reports of esophageal cancer with oral bisphosphonate use.
    The New England journal of medicine, 2009, Apr-23, Volume: 360, Issue:17

    Topics: Administration, Oral; Bone Density Conservation Agents; Calcitonin; Diphosphonates; Esophageal Neoplasms; Humans; Incidence; Osteoporosis; Raloxifene Hydrochloride; SEER Program; United States

2009
Effect of estrogen on growth and apoptosis in esophageal adenocarcinoma cells.
    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, 2013, Volume: 26, Issue:6

    Topics: Adenocarcinoma; Apoptosis; Barrett Esophagus; Cadherins; Cell Count; Cell Culture Techniques; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Esophageal Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ki-67 Antigen; Male; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen

2013